Skip to main content

Table 1 Laboratory features of the diffuse cutaneous systemic sclerosis patients with pulmonary hypertension and small vessel (cryoglobulinemic) vasculitic rash

From: Potential effect of Sildenafil beyond pulmonary hypertension in a patient with diffuse systemic sclerosis and cryoglobulinemic vasculitis

Laboratory investigations

Hb (g/dl)

15.6

WBC (Ă—103/mm3)

5.6

Platelets (Ă—103/mm3)

246

CK (U/L)

81

LDH (U/L)

691

ESR (mm/1st hr)

114

Sodium (mmol/L)

142

Potassium (mmol/L)

3.8

Calcium (mg/dl)

9.2

Phosphorus (mg/dl)

3.3

PT (seconds)

17

INR

1.4

PTT (seconds)

34.3

Triglycerides (mg/dl)

102

Cholesterol (mg/dl)

127

Cholesterol/HDL

4.4

LDL/HDL

2.7

AST (U/L)

19

ALT (U/L)

7

ALP (IU/L)

59

Creatinine (mg/dl)

0.6

Urea (mg/dl)

9

SUA (mg/dl)

6.4

RF

Negative

ANA

Positive (1:40) homogeneous

Anti-ds DNA

Negative

Anti-Scl-70

Positive

Anticentromere

Negative

U1RNP

negative

Anti-Ro (U/ml)

Positive (28.2)

Anti-La (U/ml)

Positive (17.9)

ANCA

Negative

Cryoglobulinemia

Positive

HCV (PCR)

Positive

  1. Hb: Hemoglobin, WBC: White blood cells count, CK: creatine kinase, LDH: lactate dehydrogenase, ESR: Erythrocyte sedimentation rate, PT: prothrombin time, INR: Inverse neutralization ratio, PTT: partial thromboplastin time, LDL: low density lipoprotein, HDL: high density lipoprotein, AST: Aspartate transaminase, ALT: alanine transaminase, SUA: serum uric acid, RBF: rheumatoid factor, ANA: antinuclear antibody, ds DNA: double stranded deoxyribonucleic acid, Scl-70: scleroderma 70, U1RNP: Uridine 1 ribonucleoprotein, ANCA: antineutrophil cytoplasmic antibody, HCV: hepatitis C virus.